华大基因：股东询价转让初步确定定价44.1元/股

Core Points - The core viewpoint of the article is that BGI Genomics (300676) announced the preliminary transfer price of shares at 44.10 yuan per share based on the inquiry subscription situation on September 15 [1] Group 1 - BGI Genomics is conducting a non-public transfer of shares, which will not be executed through centralized bidding or block trading methods [1] - The shares acquired through the inquiry transfer cannot be transferred by the acquirer within six months after the acquisition [1]